Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
Active trials by phase
| Phase 1 | 11 | |
| Phase 1/2 | 5 | |
| Phase 2 | 9 | |
| Phase 3 | 7 |
Disease areas by active trials, top 10 of 16
Breast Cancer (6) · Colorectal Cancer (4) · Lung Cancer (3) · Psoriasis (3) · HER2-Positive Cancer (2) · Multiple Myeloma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Pancreatic Cancer (2) · Cholangiocarcinoma (1) · Chronic Myeloid Leukemia (CML) (1)
Get alerts when Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.